Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NCAB Group | NCAB | Nov 25, 2024 | 58.45 | +3.00 |
NCC A | NCCA | Nov 25, 2024 | 162.00 | +0.31 |
NCC B | NCCB | Nov 25, 2024 | 161.70 | +0.81 |
Nederman Holding | NMAN | Nov 25, 2024 | 216.50 | -1.37 |
NEL | NELO | Nov 25, 2024 | 3.08 | +2.80 |
Nelly Group | NELLY | Nov 25, 2024 | 28.75 | +0.70 |
Neobo Fastigheter | NEOBO | Nov 25, 2024 | 20.42 | -0.34 |
Neola Medical | NEOLA | Nov 25, 2024 | 2.82 | -2.76 |
Neovici Holding B | NEOB | Nov 25, 2024 | 9.89 | +4.11 |
Nepa | NEPA | Nov 25, 2024 | 19.75 | +0.77 |
Net Insight B | NETIB | Nov 25, 2024 | 6.75 | -0.15 |
Netel | NETEL | Nov 25, 2024 | 13.54 | +1.50 |
NetJobs Group | NJOB | Nov 25, 2024 | 0.32 | -4.79 |
New Nordic Healthbrands | NNH | Nov 25, 2024 | 15.60 | +4.00 |
New Wave B | NEWAB | Nov 25, 2024 | 97.40 | +0.83 |
Newbury Pharmaceuticals | NEWBRY | Nov 25, 2024 | 3.46 | +4.22 |
Newlist | NEWL | Nov 25, 2024 | 0.09 | 0.00 |
Nexam Chemical Holding | NEXAM | Nov 25, 2024 | 4.01 | -4.30 |
Nexar Group | NXAR | Nov 25, 2024 | 0.27 | +21.43 |
NextCell Pharma AB | NXTCL | Nov 25, 2024 | 1.68 | -2.89 |
NFO Drives | NFO | Nov 25, 2024 | 33.20 | -3.49 |
Ngenic | NGENIC | Nov 25, 2024 | 2.40 | +41.18 |
NGS Group | NGS | Nov 25, 2024 | 3.12 | 0.00 |
Nibe Industrier B | NIBEB | Nov 25, 2024 | 48.62 | +6.27 |
Nicoccino Holding | NICO | Nov 25, 2024 | 1.28 | -24.26 |
Nidhogg Resources Holding AB | NIDHOG | Nov 25, 2024 | 0.02 | -4.76 |
Nilsson Special Vehicles | NILS | Nov 25, 2024 | 2.72 | -8.72 |
Nilörngruppen B | NILB | Nov 25, 2024 | 67.40 | +0.60 |
Nimbus Group | BOAT | Nov 25, 2024 | 16.10 | -0.62 |
Nischer Properties | NIS | Nov 25, 2024 | 0.22 | -25.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.